Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: a systematic review
Clinical Immunology Communications
; 2022.
Article
in English
| ScienceDirect | ID: covidwho-2003936
ABSTRACT
Passive immunization with mAbs has been employed in COVID-19. We performed a systematic review of the literature assessing the endogenous humoral immune response against SARS-CoV-2 in patients treated with mAbs. Administration of mAbs in seronegative patients led to a reduction in both antibody titres and neutralizing activity against the virus.
Full text:
Available
Collection:
Databases of international organizations
Database:
ScienceDirect
Type of study:
Reviews
/
Systematic review/Meta Analysis
Language:
English
Journal:
Clinical Immunology Communications
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS